{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:16:46Z","timestamp":1793128606084,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014707","name":"Society for the Study of Theology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cgh.2024.11.007","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T12:26:25Z","timestamp":1734092785000},"page":"1890-1904.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical, Histologic, and Safety Outcomes With Long-term Maintenance Therapies for Eosinophilic Esophagitis: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0179-8929","authenticated-orcid":false,"given":"Alberto","family":"Barchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Massimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Vito","family":"Mandarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona-Rita","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Albarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ungaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Passaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Bredenoord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Vespa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.11.007_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.iac.2008.09.001","article-title":"Eosinophilic esophagitis","volume":"29","author":"Franciosi","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.cgh.2024.11.007_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.11.007_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ueg2.12220","article-title":"Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: a 6-week open-label trial of the EOS-2 Programme","volume":"10","author":"Miehlke","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2024.11.007_bib4","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1136\/gutjnl-2023-329873","article-title":"Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis","volume":"72","author":"Visaggi","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.11.007_bib5","first-page":"CD004065","article-title":"Medical treatment of eosinophilic esophagitis","volume":"7","author":"Franciosi","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2024.11.007_bib6","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1053\/j.gastro.2003.09.024","article-title":"Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years","volume":"125","author":"Straumann","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.11.007_bib7","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.dld.2021.05.017","article-title":"Diagnostic delay and misdiagnosis in eosinophilic oesophagitis","volume":"53","author":"Lenti","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2024.11.007_bib8","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"key":"10.1016\/j.cgh.2024.11.007_bib9","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.11.007_bib10","first-page":"1459","article-title":"British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults","volume":"71","author":"Dhar","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.11.007_bib11","author":"Wells"},{"key":"10.1016\/j.cgh.2024.11.007_bib12","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)","author":"Higgins","year":"2023","journal-title":"Cochrane"},{"key":"10.1016\/j.cgh.2024.11.007_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.11.007_bib14","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.11.007_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cgh.2018.05.051","article-title":"Safety and efficacy of budesonide oral suspension maintenance therapy in patients with eosinophilic esophagitis","volume":"17","author":"Dellon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib16","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.11.007_bib17","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.cgh.2020.08.027","article-title":"Effectiveness and safety of high- vs low-dose swallowed topical steroids for maintenance treatment of eosinophilic esophagitis: a multicenter observational study","volume":"19","author":"Greuter","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cgh.2018.05.045","article-title":"Maintenance treatment of eosinophilic esophagitis with swallowed topical steroids alters disease course over a 5-year follow-up period in adult patients","volume":"17","author":"Greuter","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10620-020-06192-8","article-title":"Effect of maintenance therapy for eosinophilic esophagitis on need for recurrent dilation","volume":"66","author":"Schupack","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.11.007_bib20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MPG.0000000000001952","article-title":"Long-term treatment with proton pump inhibitors is effective in children with eosinophilic esophagitis","volume":"67","author":"Guti\u00e9rrez-Junquera","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2024.11.007_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MPG.0000000000003660","article-title":"Proton pump inhibitor therapy in pediatric eosinophilic esophagitis: predictive factors and long-term step-down efficacy","volume":"76","author":"Guti\u00e9rrez-Junquera","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2024.11.007_bib22","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.cgh.2020.08.020","article-title":"STAT6 variants associate with relapse of eosinophilic esophagitis in patients receiving long-term proton pump inhibitor therapy","volume":"19","author":"Mougey","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib23","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2015.314","article-title":"Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis","volume":"110","author":"Molina-Infante","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.11.007_bib24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.dld.2022.03.006","article-title":"Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis","volume":"54","author":"Thakkar","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2024.11.007_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.anai.2012.02.024","article-title":"Conservative long-term treatment of children with eosinophilic esophagitis","volume":"108","author":"Levine","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.cgh.2024.11.007_bib26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ajg.2016.238","article-title":"Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis","volume":"111","author":"Andreae","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.11.007_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.27","article-title":"Diminishing effectiveness of long-term maintenance topical steroid therapy in PPI non-responsive eosinophilic esophagitis","volume":"8","author":"Eluri","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2024.11.007_bib28","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/j.cgh.2021.09.020","article-title":"Maintenance therapy with the lowest effective dose of oral viscous budesonide in children with eosinophilic esophagitis","volume":"20","author":"Oliva","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib29","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cgh.2022.02.013","article-title":"Fluticasone propionate orally disintegrating tablet (APT-1011) for eosinophilic esophagitis: randomized controlled trial","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib30","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa2312282","article-title":"Dupilumab for eosinophilic esophagitis in patients 1 to 11 years of age","volume":"390","author":"Chehade","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.11.007_bib31","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","article-title":"Dupilumab in adults and adolescents with eosinophilic esophagitis","volume":"387","author":"Dellon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.11.007_bib32","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2313318","article-title":"Eosinophil depletion with benralizumab for eosinophilic esophagitis","volume":"390","author":"Rothenberg","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.11.007_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cgh.2020.03.036","article-title":"Long-term efficacy and tolerability of RPC4046 in an open-label extension trial of patients with eosinophilic esophagitis","volume":"19","author":"Dellon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S2468-1253(23)00204-2","article-title":"Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"8","author":"Rothenberg","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib35","author":"Weisfeld","year":"2023"},{"key":"10.1016\/j.cgh.2024.11.007_bib36","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1016\/S0016-5085(24)00828-X","article-title":"635 Efficacy and safety of the selective sphingosine 1-phosphate receptor modulator, etrasimod, in adult patients with eosinophilic esophagitis over 52 weeks in the phase 2 voyage study","volume":"166","author":"Dellon","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.11.007_bib37","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.cgh.2021.06.020","article-title":"Long-term treatment of eosinophilic esophagitis with budesonide oral suspension","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.11.007_bib38","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.17554\/j.issn.2224-3992.2018.07.750","article-title":"Compounded oral viscous budesonide is effective and provides a durable response in eosinophilic esophagitis","volume":"7","author":"Reed","year":"2018","journal-title":"HSOA J Gastroenterol Hepatol Res"},{"key":"10.1016\/j.cgh.2024.11.007_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/apt.12413","article-title":"Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis","volume":"38","author":"Dellon","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.11.007_bib40","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/j.gastro.2014.08.028","article-title":"Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis","volume":"147","author":"Schoepfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.11.007_bib41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.gastro.2015.11.004","article-title":"Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis","volume":"150","author":"Safroneeva","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.11.007_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O\u2019Shea","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.11.007_bib43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ajg.2013.71","article-title":"ACG clinical guideline: evidence-based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.11.007_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MPG.0b013e3182a80be1","article-title":"Management guidelines of eosinophilic esophagitis in childhood","volume":"58","author":"Papadopoulou","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2024.11.007_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2024.11.007_bib46","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.gie.2022.05.013","article-title":"Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference","volume":"96","author":"Aceves","year":"2022","journal-title":"Gastrointest Endosc"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524010693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524010693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:54:21Z","timestamp":1758704061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524010693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1542356524010693"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.11.007","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, Histologic, and Safety Outcomes With Long-term Maintenance Therapies for Eosinophilic Esophagitis: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute","name":"copyright","label":"Copyright"}]}}